Asoprisnil

Asoprisnil
Clinical data
ATC code	None;
Identifiers
	IUPAC name (8S,11R,13S,14S,17S)-11-[4-[(E)-hydroxyiminomethyl]phenyl]-17-methoxy-17-(methoxymethyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one;
JSmol)	Interactive image;
	SMILES O=C5\C=C4/C(=C3/[C@@H](c1ccc(\C=N\O)cc1)C[C@]2([C@@H](CC[C@@]2(OC)COC)[C@@H]3CC4)C)CC5;
	InChI InChI=1S/C28H35NO4/c1-27-15-24(19-6-4-18(5-7-19)16-29-31)26-22-11-9-21(30)14-20(22)8-10-23(26)25(27)12-13-28(27,33-3)17-32-2/h4-7,14,16,23-25,31H,8-13,15,17H2,1-3H3/b29-16+/t23-,24+,25-,27-,28+/m0/s1 ; Key:GJMNAFGEUJBOCE-MEQIQULJSA-N ;
	(what is this?) (verify)

Asoprisnil (

uterine fibroids.^[1] In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.^[2]

References

^ Schering Interim Report Q1-3 2005

v
t
e

Retrieved from "https://en.wikipedia.org/w/index.php?title=Asoprisnil&oldid=1084692834"